在SMA中,突触失衡和增加的抑制会损害运动功能
Emily V Fletcher1,2, Joshua I Chalif1,2, Travis M Rotterman3
1Center for Motor Neuron Biology and Disease, Columbia University, New York, NY, 10032, USA.
bioRxiv : the preprint server for biology
|September 11, 2024
概括
脊髓肌缩 (SMA) 运动回路无法平衡刺激和抑制,增加抑制和损害运动神经元功能. 减少这种抑制可以改善神经元功能,并为SMA小鼠提供行为益处.
科学领域:
- 神经科学是一个神经科学.
- 发动机的电路结构
- 突触性可塑性 突触性可塑性
背景情况:
- 均衡的兴奋抑制对于运动控制至关重要.
- 恒温机制通常会抵消神经传递干扰.
- 调节失调可能会导致神经退行性疾病,如脊髓肌肉缩 (SMA).
研究的目的:
- 调查激发抑制不平衡在SMA发病过程中的作用.
- 揭示失衡的神经传递对SMA运动电路功能障碍的贡献.
主要方法:
- 鼠标遗传学 鼠标遗传学
- 功能性测试是指功能性测试.
- 形态学分析 形态学分析
- 病毒介导的基因传递
主要成果:
- SMA 电机电路对刺激减少表现出受损的平静反应,抑制增加.
- 这种不平衡会给运动神经元带来过度的负担,阻碍肌肉的激活.
- 从遗传或药理上减少抑制驱动可以改善神经元功能障碍,并改善SMA小鼠的行为.
结论:
- 缺乏激发抑制平衡是SMA的一个关键的不适应机制.
- 联合减少刺激和增加抑制会损害运动神经元招募和肌肉收缩.
- 向抑制途径为SMA提供了治疗潜力.
相关概念视频
Chemical Synapses
8.8K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.8K
Neuromuscular Junction And Blockade
3.0K
The site of chemical communication between a motor neuron and a muscle fiber is called the neuromuscular junction (NMJ). The end of the motor neuron at the NMJ divides into a cluster of synaptic end bulbs. The cytoplasm of these bulbs consists of synaptic vesicles enclosing acetylcholine molecules, the principal neurotransmitter released at the NMJ. The region opposite the synaptic bulb that ends in the muscle fiber is called the motor end plate, which has acetylcholine receptors. Within the...
3.0K
Myasthenia Gravis: Overview and Treatment
1.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.3K
Disorders of the Skeletal Muscle
904
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
904
Cross-bridge Cycle
117.1K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.1K
Satellite Stem Cells and Muscular Dystrophy
1.9K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
1.9K


